CMS assigns Q codes to procedures, services, and supplies on a temporary basis. When a permanent code is assigned, the Q code is deleted and cross-referenced.

View All HCPCS Sections

• Q0483

  Monitor/display module for use with electric ventricular assist device, replacement only

• Q0484

  Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only

• Q0485

  Monitor control cable for use with electric ventricular assist device, replacement only

• Q0486

  Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only

• Q0487

  Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only

• Q0488

  Power pack base for use with electric ventricular assist device, replacement only

• Q0489

  Power pack base for use with electric/pneumatic ventricular assist device, replacement only

• Q0490

  Emergency power source for use with electric ventricular assist device, replacement only

• Q0491

  Emergency power source for use with electric/pneumatic ventricular assist device, replacement only

• Q0492

  Emergency power supply cable for use with electric ventricular assist device, replacement only

• Q0493

  Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only

• Q0494

  Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only

• Q0495

  Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only

• Q0496

  Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only

• Q0497

  Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only

• Q0498

  Holster for use with electric or electric/pneumatic ventricular assist device, replacement only

• Q0499

  Belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only

• Q0500

  Filters for use with electric or electric/pneumatic ventricular assist device, replacement only

• Q0501

  Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only

• Q0502

  Mobility cart for pneumatic ventricular assist device, replacement only

• Q0503

  Battery for pneumatic ventricular assist device, replacement only, each

• Q0504

  Power adapter for pneumatic ventricular assist device, replacement only, vehicle type

• Q0506

  Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only

• Q0507

  Miscellaneous supply or accessory for use with an external ventricular assist device

• Q0508

  Miscellaneous supply or accessory for use with an implanted ventricular assist device

• Q0509

  Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a

• Q0510

  Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant

• Q0511

  Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period

• Q0512

  Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period

• Q0513

  Pharmacy dispensing fee for inhalation drug(s); per 30 days

• Q0514

  Pharmacy dispensing fee for inhalation drug(s); per 90 days

• Q0515

  Injection, sermorelin acetate, 1 microgram

• Q0516

  Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days

• Q0517

  Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days

• Q0518

  Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days

• Q0519

  Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days

• Q0520

  Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days

• Q0521

  Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription

• Q1004

  New technology intraocular lens category 4 as defined in federal register notice

• Q1005

  New technology intraocular lens category 5 as defined in federal register notice

• Q2004

  Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml

• Q2009

  Injection, fosphenytoin, 50 mg phenytoin equivalent

• Q2017

  Injection, teniposide, 50 mg

• Q2026

  Injection, radiesse, 0.1 ml

• Q2028

  Injection, sculptra, 0.5 mg

• Q2034

  Influenza virus vaccine, split virus, for intramuscular use (agriflu)

• Q2035

  Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)

• Q2036

  Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)

• Q2037

  Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)

• Q2038

  Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 7/19/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.